Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cetuximab Plus Gemcitabine-Oxaliplatin (GEMOX) in Patients With Unresectable Advanced or Metastatic Biliary Tract Cancer: a Phase II Study

NCT01216345 is registered in ClinicalTrials.gov with Association of Research on the Biology of Liver Tumors as lead sponsor.

NCT NCT01216345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01216345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cetuximab Plus Gemcitabine-Oxaliplatin (GEMOX) in Patients With Unresectable Advanced or Metastatic Biliary Tract Cancer: a Phase II Study
Lead sponsor
Association of Research on the Biology of Liver Tumors
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2009
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced, metastatic, unresectable